AVRW.US Avenir Wellness Solutions Inc.

Consumer Defensive Pharmaceuticals USA Stocks
0.0002 USD
Close of Nov 10, 2026
0.0001 0.0404
Market cap
USD 16.6K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2024.

Is AVRW.US undervalued?

Graham number

The Graham number of Avenir Wellness Solutions Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Avenir Wellness Solutions Inc. fundamental analysis

No fundamental analysis for Avenir Wellness Solutions Inc. yet.

Avenir Wellness Solutions Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Avenir Wellness Solutions Inc.

Avenir Wellness Solutions, Inc., together with its subsidiary, The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in dosage forms for wellness. The company offers its products in the health, wellness, and beauty sectors under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. It sells its products to direct-to-consumer through online website orders, including opt-in subscribe and save option, as…

Full company profile